Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.05 USD | -0.39% | -2.13% | -19.52% |
May. 15 | Sector Update: Health Care Stocks Advance Late Wednesday Afternoon | MT |
May. 15 | T2 Biosystems Shares Rise After CRG Servicing Ups Stake | MT |
Financials (USD)
Sales 2024 * | 10.5M | Sales 2025 * | 23.1M | Capitalization | 86.35M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | -47M | EV / Sales 2024 * | 8.22 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.74 x |
P/E ratio 2024 * |
-1.37
x | P/E ratio 2025 * |
-3.61
x | Employees | 113 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 28.09% |
Latest transcript on T2 Biosystems, Inc.
1 day | -0.39% | ||
1 week | -2.13% | ||
Current month | +50.52% | ||
1 month | +50.52% | ||
3 months | -4.36% | ||
6 months | +42.66% | ||
Current year | -19.52% |
Managers | Title | Age | Since |
---|---|---|---|
John Sperzel
CEO | Chief Executive Officer | 60 | 20-01-07 |
John Sprague
DFI | Director of Finance/CFO | 65 | 18-01-29 |
Roger Smith
CTO | Chief Tech/Sci/R&D Officer | 59 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Elsbree
BRD | Director/Board Member | 76 | 14-06-30 |
Seymour Liebman
BRD | Director/Board Member | 74 | 16-09-20 |
Robin Toft
BRD | Director/Board Member | 63 | 20-06-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-30 | 5.06 | -0.59% | 54,217 |
24-05-29 | 5.09 | +0.59% | 73,860 |
24-05-28 | 5.06 | +2.22% | 165,893 |
24-05-24 | 4.95 | -4.07% | 150,350 |
24-05-23 | 5.16 | -8.35% | 148,128 |
Delayed Quote Nasdaq, May 30, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.52% | 86.35M | |
+6.02% | 215B | |
+9.25% | 187B | |
+19.58% | 143B | |
+29.74% | 110B | |
+1.37% | 64.68B | |
+15.27% | 52.96B | |
+2.69% | 49.84B | |
-5.47% | 38.32B | |
+1.58% | 35.86B |
- Stock Market
- Equities
- TTOO Stock